Search research articles
Contact Us
Filters
Showing results (91-100 of 301) with videos related to
Page
of 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1994
Gene transfer in tumor therapy
G Forni, G Parmiani, A Guarini, et al.
International Journal of Cancer
|
September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability
A Anichini, R Mortarini, R Supino, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors
M Sensi, L Grazioli, M Rodolfo, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
T-cell recognition of melanoma antigens and its therapeutic applications
C Castelli, L Rivoltini, A Mazzocchi, et al.
Cancer Research
|
November 24, 2001
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells
G Pietra, R Mortarini, G Parmiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Vaccination of patients with solid tumours
G Parmiani, L Pilla, C Castelli, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin
R Supino, M Mariani, E Prosperi, et al.
International Journal of Cancer
|
February 15, 1990
Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations
R Mortarini, F Belli, G Parmiani, et al.
International Journal of Cancer
|
December 15, 1990
Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity
M Sensi, M Bergomi, F Formelli, et al.
Melanoma Research
|
July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?
G Parmiani, A Anichini, G Carbone, et al.
Page
of 31
Search research articles
Search
Showing results (91-100 of 301) with videos related to
Sort By:
Page
of 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1994
Gene transfer in tumor therapy
G Forni, G Parmiani, A Guarini, et al.
International Journal of Cancer
|
September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability
A Anichini, R Mortarini, R Supino, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors
M Sensi, L Grazioli, M Rodolfo, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
T-cell recognition of melanoma antigens and its therapeutic applications
C Castelli, L Rivoltini, A Mazzocchi, et al.
Cancer Research
|
November 24, 2001
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells
G Pietra, R Mortarini, G Parmiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Vaccination of patients with solid tumours
G Parmiani, L Pilla, C Castelli, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin
R Supino, M Mariani, E Prosperi, et al.
International Journal of Cancer
|
February 15, 1990
Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations
R Mortarini, F Belli, G Parmiani, et al.
International Journal of Cancer
|
December 15, 1990
Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity
M Sensi, M Bergomi, F Formelli, et al.
Melanoma Research
|
July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?
G Parmiani, A Anichini, G Carbone, et al.
Page
of 31